- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Wilson disease
- Meeting Date: May 2022
- Public Summary Document (PSD) May 2022 PBAC Meeting - (PDF 537KB)
- Public Summary Document (PSD) May 2022 PBAC Meeting - (Word 87KB)
Trientine – May 2022
Trientine: Capsule containing trientine dihydrochloride 250 mg (equivalent to 166.7 mg trientine); Waymade®
Last updated
11 October 2022